Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line

Clinical trial NCT03462251 · COMPLETED

Trial details

NCT number: NCT03462251
Sponsor: iOMEDICO AG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Hormone Receptor Positive Tumor HER 2 Negative Breast Cancer

Start date: 2018-05-24
Primary completion: 2021-11-30
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.